Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00311974Phase 4Completed
Phase 4 trial of dihydralazine in hypertension (HTN), sponsored by Regionshospitalet Holstebro. Primary endpoints: Fractional sodium excretion, Heart rate and 1 more. Started Apr 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00311974.